|
Volumn 168, Issue 4, 2002, Pages 1618-1626
|
Vascular endothelial-junctional adhesion molecule (VE-JAM)/JAM 2 interacts with T, NK, and dendritic cells through JAM 3
a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
A33 ANTIGEN;
ANTIGEN;
CD3 ANTIGEN;
CD56 ANTIGEN;
CD8 ANTIGEN;
CELL ADHESION MOLECULE;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
INTERLEUKIN 4;
JUNCTIONAL ADHESION MOLECULE 3;
LYMPHOCYTE ANTIGEN RECEPTOR;
UNCLASSIFIED DRUG;
VASCULAR ENDOTHELIAL JUNCTIONAL ADHESION MOLECULE;
VASCULAR ENDOTHELIAL JUNCTIONAL ADHESION MOLECULE RECEPTOR;
ANIMAL EXPERIMENT;
ARTERY ENDOTHELIUM;
ARTICLE;
CELL STRAIN;
CONTROLLED STUDY;
CYTOTOXIC T LYMPHOCYTE;
DENDRITIC CELL;
EXPRESSED SEQUENCE TAG;
FEMALE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
INFLAMMATION;
LEUKOCYTE ADHERENCE;
LYMPH NODE;
MALE;
MOLECULAR CLONING;
MOUSE;
NATURAL KILLER CELL;
NONHUMAN;
ORGAN DISTRIBUTION;
PRIORITY JOURNAL;
PROTEIN FUNCTION;
PROTEIN PROTEIN INTERACTION;
SEQUENCE HOMOLOGY;
SIGNAL TRANSDUCTION;
T LYMPHOCYTE;
TONSIL;
TUMOR;
|
EID: 0037083419
PISSN: 00221767
EISSN: None
Source Type: Journal
DOI: 10.4049/jimmunol.168.4.1618 Document Type: Article |
Times cited : (126)
|
References (14)
|